Zavicefta

Zavicefta combines ceftazidime and avibactam for targeted antibacterial therapy. Designed for intravenous use, it supports treatment of complex infections. This combination addresses resistant gram-negative bacteria effectively. Ideal for hospital and clinical settings requiring broad-spectrum coverage.

Zavicefta is used to treat serious bacterial infections, including those caused by resistant gram-negative organisms. It is prescribed for complicated intra-abdominal infections and urinary tract infections when other treatments are ineffective. Healthcare professionals may use it for hospital-acquired pneumonia and other severe conditions requiring intravenous antibacterial therapy.

As an intravenous antibacterial, Zavicefta works by targeting specific bacterial cell structures to reduce infection severity. Patients may notice improved symptoms as the medication takes effect. Common effects include resolution of fever and reduction in infection-related discomfort over time.

Store Zavicefta as directed by healthcare providers, typically at controlled room temperature. Protect from moisture and light to maintain potency. Always use sterile techniques during preparation and administration to prevent contamination. Follow medical guidance for handling and disposal of intravenous medications.

Zavicefta may interact with other medications that affect kidney function or blood thinning agents. Combining it with certain diuretics or nephrotoxic drugs could require monitoring. Always inform healthcare providers about all medications being taken to assess potential interactions before administration.